Thiogenesis Therapeutics Corp (TTI)

TSXV
Currency in CAD
0.77
-0.01(-1.28%)
Closed·
TTI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
TTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.770.80
52 wk Range
0.510.88
Key Statistics
Edit
Bid/Ask
0.77 / 0.82
Prev. Close
0.78
Open
0.77
Day's Range
0.77-0.8
52 wk Range
0.51-0.88
Volume
59K
Average Volume (3m)
34.81K
1-Year Change
18.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TTI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Thiogenesis Therapeutics Corp Company Profile

Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.

Compare TTI to Peers and Sector

Metrics to compare
TTI
Peers
Sector
Relationship
P/E Ratio
−9.3x−6.0x−0.5x
PEG Ratio
−0.340.080.00
Price/Book
16.7x−3.8x2.6x
Price / LTM Sales
-3.4x3.2x
Upside (Analyst Target)
-217.6%45.4%
Fair Value Upside
Unlock−29.5%6.9%Unlock

Earnings

Latest Release
May 27, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TTI Income Statement

FAQ

What Is the Thiogenesis Therapeutics (TTI) Stock Price Today?

The Thiogenesis Therapeutics stock price today is 0.77

What Stock Exchange Does Thiogenesis Therapeutics Trade On?

Thiogenesis Therapeutics is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for Thiogenesis Therapeutics?

The stock symbol for Thiogenesis Therapeutics is "TTI."

What Is the Thiogenesis Therapeutics Market Cap?

As of today, Thiogenesis Therapeutics market cap is 35.66M.

What Is Thiogenesis Therapeutics's Earnings Per Share (TTM)?

The Thiogenesis Therapeutics EPS (TTM) is -0.08.

When Is the Next Thiogenesis Therapeutics Earnings Date?

Thiogenesis Therapeutics will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is TTI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Thiogenesis Therapeutics Stock Split?

Thiogenesis Therapeutics has split 0 times.

How Many Employees Does Thiogenesis Therapeutics Have?

Thiogenesis Therapeutics has 0 employees.

What is the current trading status of Thiogenesis Therapeutics (TTI)?

As of 12 July 2025, Thiogenesis Therapeutics (TTI) is trading at a price of 0.77, with a previous close of 0.78. The stock has fluctuated within a day range of 0.77 to 0.80, while its 52-week range spans from 0.51 to 0.88.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.